Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 3, 2010, Pages 257-264

  Zarychanski, Ryan ^a,b   Stuart, Tammy L ^c   Kumar, Anand ^a,d   Doucette, Steve ^e   Elliott, Lawrence ^a,f   Kettner, Joel ^a,f   Plummer, Frank ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Department of Anesthesiology   (United States)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f Manitoba Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CANADA; CASE CONTROL STUDY; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; AMERICAN INDIAN; CHRONIC DISEASE; EPIDEMIC; EPIDEMIOLOGY; ETHNOLOGY; HOSPITALIZATION; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL AGENTS; CANADA; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; DISEASE OUTBREAKS; FEMALE; GUIDELINES AS TOPIC; HOSPITALIZATION; HUMANS; INDIANS, NORTH AMERICAN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; MANITOBA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77951805437     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091884     Document Type: Article

References (18)

1. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887
2. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-1879
3. Webb SA, Pettila V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-1934
4. Intensive-care patients with severe novel influenza A(H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752
5. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009;4:e6051.
6. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944
7. Manitoba Centre for Health Policy, University of Manitoba. Concept: construction of census income quintiles. Winnipeg (MB): The Centre; 2008. Available: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?conceptID=1056 (accessed 2009 Nov. 19).
8. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-1373
9. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003;51:123-129
10. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568-1575
11. Lee N, Cockram CS, Chan PK, et al. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis 2008;46:1323-1324
12. Graham-Cumming G. Health of the original Canadians, 1867-1967. Med Serv J Can 1967;23:115-166
13. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-115
14. Cleland-Burton J. Disease among the Australian Aborigines. J Trop Med Hyg 1928;6:65-72.
15. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005;307:1434-1440
16. Hardie RA, Luo M, Bruneau B, et al. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection. AIDS 2008;22:807-816 (Pubitemid 351563829)
17. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-801.
18. Rothman K, Greenland S, Lash T. Validity in epidemiologic studies. In: Modern epidemiology. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.